Cargando…
Human epidermal growth factor receptor 2-positive microinvasive breast carcinoma with a highly aggressive course: a case report
BACKGROUND: Microinvasive ductal carcinoma in situ of the breast is a rare entity defined as ductal carcinoma in situ with invasive foci measuring no more than 1 mm. In general, the outcome is excellent, similar to ductal carcinoma in situ. We report a patient with breast ductal carcinoma in situ wi...
Autores principales: | Grasic Kuhar, Cvetka, Matos, Erika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046443/ https://www.ncbi.nlm.nih.gov/pubmed/24884941 http://dx.doi.org/10.1186/1756-0500-7-325 |
Ejemplares similares
-
Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer
por: Kuhar, Cvetka Grašič, et al.
Publicado: (2023) -
Effectiveness of adjuvant trastuzumab in daily clinical practice
por: Matos, Erika, et al.
Publicado: (2014) -
Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population
por: Grasic Kuhar, Cvetka, et al.
Publicado: (2023) -
Digital ischemic events related to gemcitabine: Report of two cases and a systematic review
por: Kuhar, Cvetka Grasic, et al.
Publicado: (2010) -
Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors
por: Mesti, Tanja, et al.
Publicado: (2023)